Bednár M, Mára M
Department of Medical Microbiology and Immunology, Faculty of Medicine, Charles University, Prague, Czechoslovakia.
Zentralbl Bakteriol. 1991 Jan;274(4):527-32. doi: 10.1016/s0934-8840(11)80091-5.
In mice killed Rothia dentocariosa cells in doses of about 1.5 mg dry weight activated anti-infection immunity to Listeria antigens and anti-tumour immunity to the ascitic form of mouse sarcoma S-180. Their probable target site is the macrophage. The Rothia-activated macrophages in human gingiva may take part in the pathogenesis of periodontal disease. Three models were employed to verify the immunostimulating properties of preventively administered Rothia dentocariosa bacterin-1) a spleen macrophage migration test, using mice immunized with Listeria innocua, with the soluble listeria Ei antigen as the antigenic signal, 2) determination of the increase in the Listeria monocytogenes LD50 for mice and 3) the prolongation of survival of mice carrying the S-180 tumour. In all three cases, the administration of Rothia bacterin stimulated the immune response to the later administration of other antigens. Furthermore, in the macrophage migration inhibition test, the chemotaxis of non-immune mouse macrophages was found to be stimulated. This gives evidence of the fact that Rothia bacterin has an activating effect on these macrophages.
在小鼠中,约1.5毫克干重剂量的龋齿罗氏菌细胞可激活对李斯特菌抗原的抗感染免疫力以及对小鼠肉瘤S-180腹水型的抗肿瘤免疫力。其可能的靶位点是巨噬细胞。人牙龈中经龋齿罗氏菌激活的巨噬细胞可能参与牙周病的发病机制。采用三种模型来验证预防性接种龋齿罗氏菌菌苗的免疫刺激特性:1)脾脏巨噬细胞迁移试验,用无毒李斯特菌免疫小鼠,以可溶性李斯特菌Ei抗原作为抗原信号;2)测定小鼠对单核细胞增生李斯特菌的半数致死量(LD50)的增加;3)携带S-180肿瘤小鼠存活时间的延长。在所有这三种情况下,接种龋齿罗氏菌菌苗均刺激了对随后接种其他抗原的免疫反应。此外,在巨噬细胞迁移抑制试验中,发现非免疫小鼠巨噬细胞的趋化性受到刺激。这证明了龋齿罗氏菌菌苗对这些巨噬细胞具有激活作用。